Maternal serum fatty acid binding protein-4 level is upregulated in fetal growth restriction with abnormal Doppler flow patterns.
IUGR
fetal growth assessment
Journal
The journal of obstetrics and gynaecology research
ISSN: 1447-0756
Titre abrégé: J Obstet Gynaecol Res
Pays: Australia
ID NLM: 9612761
Informations de publication
Date de publication:
26 Dec 2023
26 Dec 2023
Historique:
received:
09
08
2023
accepted:
11
12
2023
medline:
27
12
2023
pubmed:
27
12
2023
entrez:
26
12
2023
Statut:
aheadofprint
Résumé
This study aimed to determine fatty acid binding protein-4 (FABP-4) concentrations in maternal serum of fetal growth restriction (FGR) pregnancies and controls of normal pregnancies. Furthermore, we hypothesized that the alterations in FABP-4 levels might correlate with FGR severity. We performed this prospective case-control study with 83 pregnant women. The study groups included 26 FGR pregnancies without abnormal fetal Doppler flow patterns and 25 pregnancies complicated with FGR accompanied by abnormal fetal Doppler flow patterns. The median serum FABP-4 concentrations were significantly higher in the FGR cases with abnormal Doppler flow pattern group (2.09 ng/mL) than in the FGR cases without abnormal Doppler flow pattern group (1.62 ng/mL) and the control group (1.20 ng/mL, p < 0.001). A significant negative correlation was observed between maternal serum FABP-4 levels and time to birth from blood sample collection (r = -0.356 and p = 0.001), gestational week at birth (r = -0.386 and p < 0.001), and birth weight (r = -0.394 and p < 0.001). A 1.35 ng/mL cut-off value of serum FABP-4 level could be used to discriminate FGR cases with a 78.4% sensitivity and 60.6% specificity. The optimal cut-off value of FABP-4 levels as an indicator for the diagnosis of FGR with abnormal Doppler flow pattern was estimated to be 1.76 ng/mL, which yielded a sensitivity of 84.0% and a specificity of 75.8%. FABP-4 is a crucial biomarker in the diagnosis and determining the severity of pregnancies with restricted fetal growth. We consider that FABP-4 is a powerful, reliable, and unique biomarker to diagnose FGR pregnancies.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023 Japan Society of Obstetrics and Gynecology.
Références
Nardozza LM, Caetano AC, Zamarian AC, Mazzola JB, Silva CP, Marçal VM, et al. Fetal growth restriction: current knowledge. Arch Gynecol Obstet. 2017;295:1061-1077. https://doi.org/10.1007/s00404-017-4341-9
Oğlak SC, Bademkıran MH, Obut M. Predictor variables in the success of slow-release dinoprostone used for cervical ripening in intrauterine growth restriction pregnancies. J Gynecol Obstet Hum Reprod. 2020;49:101739. https://doi.org/10.1016/j.jogoh.2020.101739
Porter B, Maulik D, Babbar S, Schrufer-Poland T, Allsworth J, Ye SQ, et al. Maternal plasma soluble neuropilin-1 is downregulated in fetal growth restriction complicated by abnormal umbilical artery Doppler: a pilot study. Ultrasound Obstet Gynecol. 2021;58:716-721. https://doi.org/10.1002/uog.23605
Figueras F, Caradeux J, Crispi F, Eixarch E, Peguero A, Gratacos E. Diagnosis and surveillance of late-onset fetal growth restriction. Am J Obstet Gynecol. 2018;218(2S):S790-S802.e1. https://doi.org/10.1016/j.ajog.2017.12.003
Gaccioli F, Aye ILMH, Sovio U, Charnock-Jones DS, Smith GCS. Screening for fetal growth restriction using fetal biometry combined with maternal biomarkers. Am J Obstet Gynecol. 2018;218:S725-S737. https://doi.org/10.1016/j.ajog.2017.12.002
Behram M, Oğlak SC, Dağ İ. Circulating levels of Elabela in pregnant women complicated with intrauterine growth restriction. J Gynecol Obstet Hum Reprod. 2021;50:102127. https://doi.org/10.1016/j.jogoh.2021.102127
Haggarty P. Fatty acid supply to the human fetus. Annu Rev Nutr. 2010;30:237-255. https://doi.org/10.1146/annurev.nutr.012809.104742
Haggarty P. Meeting the fetal requirement for polyunsaturated fatty acids in pregnancy. Curr Opin Clin Nutr Metab Care. 2014;17:151-155. https://doi.org/10.1097/MCO.0000000000000036
Rebholz SL, Burke KT, Yang Q, Tso P, Woollett LA. Dietary fat impacts fetal growth and metabolism: uptake of chylomicron remnant core lipids by the placenta. Am J Physiol Endocrinol Metab. 2011;301:E416-E425. https://doi.org/10.1152/ajpendo.00619.2010
Tuuri AL, Jauhiainen MS, Tikkanen MJ, Kaaja RJ. Systolic blood pressure and fatty acid-binding protein 4 predict pregnancy-induced hypertension in overweight nulliparous women. Placenta. 2014;35:797-801. https://doi.org/10.1016/j.placenta.2014.07.016
Ning H, Tao H, Weng Z, Zhao X. Plasma fatty acid-binding protein 4 (FABP4) as a novel biomarker to predict gestational diabetes mellitus. Acta Diabetol. 2016;53:891-898. https://doi.org/10.1007/s00592-016-0867-8
Scifres CM, Catov JM, Simhan H. Maternal serum fatty acid binding protein 4 (FABP4) and the development of preeclampsia. J Clin Endocrinol Metab. 2012;97:E349-E356. https://doi.org/10.1210/jc.2011-2276
Hotamisligil GS, Bernlohr DA. Metabolic functions of FABPs-mechanisms and therapeutic implications. Nat Rev Endocrinol. 2015;11:592-605. https://doi.org/10.1038/nrendo.2015.122
Scifres CM, Chen B, Nelson DM, Sadovsky Y. Fatty acid binding protein 4 regulates intracellular lipid accumulation in human trophoblasts. J Clin Endocrinol Metab. 2011;96:E1083-E1091. https://doi.org/10.1210/jc.2010-2084
Cao H, Sekiya M, Ertunc ME, Burak MF, Mayers JR, White A, et al. Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production. Cell Metab. 2013;17:768-778. https://doi.org/10.1016/j.cmet.2013.04.012
American College of Obstetricians and Gynecologists' Committee on Practice Bulletins-Obstetrics and the Society forMaternal-FetalMedicin. ACOG practice bulletin No. 204: fetal growth restriction. Obstet Gynecol. 2019;133:e97-e109. https://doi.org/10.1097/AOG.0000000000003070
Stirnemann J, Villar J, Salomon LJ, Ohuma E, Ruyan P, Altman DG, et al. International estimated fetal weight standards of the INTERGROWTH-21st project. Ultrasound Obstet Gynecol. 2017;49:478-486. https://doi.org/10.1002/uog.17347
Committee opinion no 700: methods for estimating the due date. Obstet Gynecol. 2017;129:e150-e154. https://doi.org/10.1097/AOG.0000000000002046
Papathanasiou AE, Briana DD, Gavrili S, Georgantzi S, Papathoma E, Marmarinos A, et al. Cord blood fatty acid-binding protein-4 levels are upregulated at both ends of the birthweight spectrum. Acta Paediatr. 2019;108:2083-2088. https://doi.org/10.1111/apa.14826
Ferchaud-Roucher V, Kramer A, Silva E, Pantham P, Weintraub ST, Jansson T, et al. A potential role for lysophosphatidylcholine in the delivery of long chain polyunsaturated fatty acids to the fetal circulation. Biochim Biophys Acta Mol Cell Biol Lipids. 2019;1864:394-402. https://doi.org/10.1016/j.bbalip.2018.12.007
Makowski L, Hotamisligil GS. Fatty acid binding proteins-the evolutionary crossroads of inflammatory and metabolic responses. J Nutr. 2004;134:2464S-2468S. https://doi.org/10.1093/jn/134.9.2464S
Biron-Shental T, Schaiff WT, Ratajczak CK, Bildirici I, Nelson DM, Sadovsky Y. Hypoxia regulates the expression of fatty acid-binding proteins in primary term human trophoblasts. Am J Obstet Gynecol. 2007;197(516):e1-e6. https://doi.org/10.1016/j.ajog.2007.03.066
Makkar A, Mishima T, Chang G, Scifres C, Sadovsky Y. Fatty acid binding protein-4 is expressed in the mouse placental labyrinth, yet is dispensable for placental triglyceride accumulation and fetal growth. Placenta. 2014;35:802-807. https://doi.org/10.1016/j.placenta.2014.07.008
Chassen SS, Ferchaud-Roucher V, Gupta MB, Jansson T, Powell TL. Alterations in placental long chain polyunsaturated fatty acid metabolism in human intrauterine growth restriction. Clin Sci (Lond). 2018;132:595-607. https://doi.org/10.1042/CS20171340
Chassen SS, Ferchaud-Roucher V, Palmer C, Li C, Jansson T, Nathanielsz PW, et al. Placental fatty acid transport across late gestation in a baboon model of intrauterine growth restriction. J Physiol. 2020;598:2469-2489. https://doi.org/10.1113/JP279398
Aragonès G, Saavedra P, Heras M, Cabré A, Girona J, Masana L. Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells. Cardiovasc Diabetol. 2012;11:72. https://doi.org/10.1186/1475-2840-11-72
Yan Y, Peng H, Wang P, Wang H, Dong M. Increased expression of fatty acid binding protein 4 in preeclamptic placenta and its relevance to preeclampsia. Placenta. 2016;39:94-100. https://doi.org/10.1016/j.placenta.2016.01.014
Ortega-Senovilla H, Schaefer-Graf U, Meitzner K, Abou-Dakn M, Graf K, Kintscher U, et al. Gestational diabetes mellitus causes changes in the concentrations of adipocyte fatty acid-binding protein and other adipocytokines in cord blood. Diabetes Care. 2011;34:2061-2066. https://doi.org/10.2337/dc11-0715